Testing effectiveness (Phase 2)Study completedNCT04571970
What this trial is testing
RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome)
Who this might be right for
Mucopolysaccharidosis Type II (MPS II)
REGENXBIO Inc. 6